SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Nidan Laboratories And Healthcare Ltd

BSE: 0 NSE: NIDAN ISIN: INE0J6L01013
  |   Sector:  Healthcare   |   Industry:  Hospital & Healthcare Services

Snapshot

Q.1 Which industry/sub-sector does Nidan Laboratories And Healthcare Ltd belong to?
Nidan Laboratories And Healthcare Ltd belongs to the Healthcare sector, operating specifically within the Hospital & Healthcare Services segment.
Q.2 Is Nidan Laboratories And Healthcare Ltd a good quality company?
Nidan Laboratories And Healthcare Ltd is a quality company, based on a 10 year financial track record.
Q.3 Is Nidan Laboratories And Healthcare Ltd undervalued or overvalued?
Nidan Laboratories And Healthcare Ltd appears Undervalued, as its key valuation ratios are below with their past averages.
Q.4 Is Nidan Laboratories And Healthcare Ltd a good buy now?
Nidan Laboratories And Healthcare Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Nidan Laboratories And Healthcare Ltd?
Nidan Laboratories And Healthcare Ltd revenue growth is 1.5% for FY-2025 , which is below its 5 year CAGR of 2.8% , indicating slower growth.
Q.2 Gross Profit margin of Nidan Laboratories And Healthcare Ltd?
Nidan Laboratories And Healthcare Ltd Gross profit margin which is the profit after deduction of direct costs, is 21.1% for FY-2025 , which is below its 5 year median of 29% , indicating decreasing margins.
Q.3 Operating Profit Margin of Nidan Laboratories And Healthcare Ltd?
Nidan Laboratories And Healthcare Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 20.64% for FY-2025 , which is below its 5 year median of 28.04% indicating decreasing margins.
Q.4 Net Profit Margin of Nidan Laboratories And Healthcare Ltd?
Nidan Laboratories And Healthcare Ltd Net Profit Margin is 8.06% for FY-2025 , is below with its 5 year median of 8.98%, indicating decreasing margins.
Current Level Historic Median
Gross Profit Margin 21.1 29
Operating Profit Margin 20.64 28.04
Net Profit Margin 8.06 8.98
Q.5 Return on Asset of Nidan Laboratories And Healthcare Ltd?
Nidan Laboratories And Healthcare Ltd Return on Asset is 2.41%, which is below its 5 year historical median of 3.76%, indicating deteriorated asset utilization efficiency.
Q.6 Return on Equity (ROE) of Nidan Laboratories And Healthcare Ltd?
Nidan Laboratories And Healthcare Ltd Return on equity is 2.94% for FY-2025 , which is below its historical median of 5.23%, indicating the business is making worse use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Nidan Laboratories And Healthcare Ltd?
Nidan Laboratories And Healthcare Ltd Return on capital employed is 6.21% for FY-2025 , which is below its estimated weighted average cost of capital(WACC) 14%, indicating value preservation.
Q.8 Cash conversion cycle of Nidan Laboratories And Healthcare Ltd?
Nidan Laboratories And Healthcare Ltd Cash conversion cycle is 0 days, below its historical median of 43 days, indicating improved working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.3 0.3
ROE 2.94 5.23
ROCE 6.21 8.5
Cash Conversion Cycle - 43 days
Q.9 Debt to Equity ratio of Nidan Laboratories And Healthcare Ltd?
Nidan Laboratories And Healthcare Ltd Debt-to-Equity ratio is 0.16 , which is lower with the industry average of 0.22 , indicating lower debt levels in the industry.
Q.10 Debt to cash flow from operations of Nidan Laboratories And Healthcare Ltd?
Nidan Laboratories And Healthcare Ltd Debt to cash flow from operations is 4.88 , which is at a unhealthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Nidan Laboratories And Healthcare Ltd?
Promoters hold 57.04% of the Nidan Laboratories And Healthcare Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Nidan Laboratories And Healthcare Ltd vs industry peers?
Nidan Laboratories And Healthcare Ltd revenue CAGR is 2.76% , compared to the industry median CAGR of 1.49% , indicating faster growth and gaining its market share.
Profit Metrics
Current Level Industry Median
Revenue 24.5 144
Gross Profit 5.2 8.2
Operating Profit 5.1 8.4
Net Profit 2 5
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.3 0.73
ROE 2.94 13.88
ROCE 6.21 17.77
Cash Conversion Cycle (days) 0.34 2

Valuation & price assessment

Q.1 Stock return of Nidan Laboratories And Healthcare Ltd over the last decade?
Over the last 3 year(s), the stock has delivered a CAGR of -26.89% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price - - -26.9% -21.3%
Q.3 Valuation ratios of Nidan Laboratories And Healthcare Ltd vs historical?
The current P/E is lower that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 11.07 12.87 79.71
Price to Book 0.32 0.69 3.54
Price to Sales 0.89 1.88 4.37
EV to EBITDA 4.25 5.60 18.04

Check more companies

1. Aster DM Healthcare
2. Global Health
3. Krishna Inst.Medi
4. Dr. Lal Pathlabs
5. Dr. Agarwals Health
6. RainbowChildrenS Med
7. Metropolis Health.
8. Vijaya Diagnostic
9. Park Medi World
10. HealthcareGlobal
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×